{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:18:49Z","timestamp":1790889529879,"version":"4.1.0"},"reference-count":156,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Rift Valley Fever (RVF) is a mosquito-borne zoonotic disease that presents a substantial threat to human and public health. It is caused by Rift Valley fever phlebovirus (RVFV), which belongs to the genus Phlebovirus and the family Phenuiviridae within the order Bunyavirales. The wide distribution of competent vectors in non-endemic areas coupled with global climate change poses a significant threat of the transboundary spread of RVFV. In the last decade, an improved understanding of the molecular biology of RVFV has facilitated significant progress in the development of novel vaccines, including DIVA (differentiating infected from vaccinated animals) vaccines. Despite these advances, there is no fully licensed vaccine for veterinary or human use available in non-endemic countries, whereas in endemic countries, there is no clear policy or practice of routine\/strategic livestock vaccinations as a preventive or mitigating strategy against potential RVF disease outbreaks. The purpose of this review was to provide an update on the status of RVF vaccine development and provide perspectives on the best strategies for disease control. Herein, we argue that the routine or strategic vaccination of livestock could be the best control approach for preventing the outbreak and spread of future disease.<\/jats:p>","DOI":"10.3390\/vaccines5030029","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T11:04:35Z","timestamp":1505819075000},"page":"29","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Current Status of Rift Valley Fever Vaccine Development"],"prefix":"10.3390","volume":"5","author":[{"given":"Bonto","family":"Faburay","sequence":"first","affiliation":[{"name":"Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"},{"name":"Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelle","family":"LaBeaud","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"McVey","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Arthropod-Borne Animal Disease Research Unit, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wilson","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Arthropod-Borne Animal Disease Research Unit, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7308-5672","authenticated-orcid":false,"given":"Juergen","family":"Richt","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"},{"name":"Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"ref_1","unstructured":"Stordy, R.J. (1913). Mortality among Lambs. 1912\u20131913, British East Africa. Annual Report Department of Agriculture."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0923-2516(89)80096-2","article-title":"Analytical study of a Rift Valley fever epidemic","volume":"140","author":"Jouan","year":"1989","journal-title":"Res. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3201\/eid2002.131000","article-title":"Rift Valley fever outbreak, southern Mauritania, 2012","volume":"20","author":"Sow","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3201\/eid2003.131174","article-title":"Rift Valley fever in Kedougou, southeastern Senegal, 2012","volume":"20","author":"Sow","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3201\/eid1712.111035","article-title":"Molecular epidemiology of Rift Valley fever virus","volume":"17","author":"Grobbelaar","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3201\/eid0812.020195","article-title":"Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01","volume":"8","author":"Shoemaker","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2460\/javma.234.7.883","article-title":"Rift Valley fever virus","volume":"234","author":"Bird","year":"2009","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"ref_10","unstructured":"Coetzer, J.A.W., Thoson, G.R., and Tustin, R.D. (2004). Rift Valley fever. Infectious Diseases of Livestock, Oxford University Press."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1473-3099(12)70305-5","article-title":"Infectious disease surveillance update: Rift Valley fever in Mauritania","volume":"12","author":"Heald","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2010.09-0288","article-title":"An investigation of a major outbreak of Rift Valley fever in Kenya: 2006\u20132007","volume":"83","author":"Nguku","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1128\/JVI.76.23.12200-12210.2002","article-title":"Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein","volume":"76","author":"Gerrard","year":"2002","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH Transcription Factor, a Target for the Rift Valley Hemorrhagic Fever Virus","volume":"116","author":"Dubaele","year":"2004","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Le May, N., Mansuroglu, Z., Leger, P., Josse, T., Blot, G., Billecocq, A., Flick, R., Jacob, Y., Bonnefoy, M., and Bouloy, M. (2008). A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.0040013"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C.J., and Makino, S. (2009). Rift Valley Fever Virus NSs Protein Promotes Post-Transcriptional Downregulation of Protein Kinase PKR and Inhibits eIF2\u03b1 Phosphorylation. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000287"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0923-2516(91)90069-F","article-title":"Antigenic analysis of Rift Valley fever virus isolates: Monoclonal antibodies distinguish between wild-type and neurotropic virus strains","volume":"142","author":"Besselaar","year":"1991","journal-title":"Res. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-2516(07)80002-1","article-title":"The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity","volume":"145","author":"Besselaar","year":"1994","journal-title":"Res. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01309641","article-title":"The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins","volume":"125","author":"Besselaar","year":"1992","journal-title":"Arch. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/vbz.2014.1650","article-title":"A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep","volume":"14","author":"Faburay","year":"2014","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27719","DOI":"10.1038\/srep27719","article-title":"A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep","volume":"6","author":"Faburay","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"ref_30","unstructured":"World Organization for Animal Health (OIE) (2017, August 25). List of Notifiable Diseases. Available online: http:\/\/www.oie.int\/animal-health-in-the-world\/oie-listed-diseases-2017\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/1469-0691.12163","article-title":"Relevance of Rift Valley fever to public health in the European Union","volume":"19","author":"Chevalier","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2987\/10-6070.1","article-title":"Potential for stable flies and house flies (Diptera: Muscidae) to transmit Rift Valley fever virus","volume":"26","author":"Turell","year":"2010","journal-title":"J. Am. Mosq. Control Assoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jme\/tjv093","article-title":"Potential for Psorophora columbiae and Psorophora ciliata Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus","volume":"52","author":"Turell","year":"2015","journal-title":"J. Med. Entomol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Golnar, A.J., Kading, R.C., and Hamer, G.L. (2017). Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States. Transbound. Emerg. Dis.","DOI":"10.1111\/tbed.12608"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Golnar, A.J., Turell, M.J., LaBeaud, A.D., Kading, R.C., and Hamer, G.L. (2014). Predicting the mosquito species and vertebrate species involved in the theoretical transmission of rift valley Fever virus in the United States. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003163"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1016\/j.vaccine.2015.08.020","article-title":"Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe","volume":"33","author":"Mansfield","year":"2015","journal-title":"Vaccine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus(Bunyaviridae: Phlebovirus): An update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift Valley fever vaccines","volume":"27","author":"Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1016\/j.vaccine.2013.09.029","article-title":"Vaccines against diseases transmitted from animals to humans: A one health paradigm","volume":"31","author":"Monath","year":"2013","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0b013e32833c3da6","article-title":"Advances in Rift Valley fever research: Insights for disease prevention","volume":"23","author":"LaBeaud","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3201\/eid1709.110506","article-title":"Rift Valley Fever Vaccine Development, Progress and Constraints","volume":"17","author":"Kortekaas","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fcimb.2012.00131","article-title":"Novel approaches to develop Rift Valley fever vaccines","volume":"2","author":"Indran","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/fvl.10.63","article-title":"Towards a safe, effective vaccine for Rift Valley fever virus","volume":"5","author":"Labeaud","year":"2010","journal-title":"Future Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2014.03.008","article-title":"One Health approach to Rift Valley fever vaccine development","volume":"106","author":"Kortekaas","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0042-6822(89)90365-6","article-title":"Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins","volume":"170","author":"Schmaljohn","year":"1989","journal-title":"Virology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.vaccine.2009.12.062","article-title":"Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"Lagerqvist","year":"2009","journal-title":"Virol. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"Mandell","year":"2010","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jviromet.2010.07.015","article-title":"Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles","volume":"169","author":"Mandell","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/JVI.07104-11","article-title":"Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge","volume":"86","author":"Dodd","year":"2012","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Oreshkova, N., van Keulen, L., Kant, J., Moormann, R.J., and Kortekaas, J. (2013). A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077461"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1017\/S0950268808001696","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","volume":"137","author":"Heise","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1743-422X-10-349","article-title":"Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice","volume":"10","author":"Warimwe","year":"2013","journal-title":"Virol. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"Bird","year":"2011","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","article-title":"T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus","volume":"89","author":"Habjan","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66 Pt 10","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"ref_66","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_67","unstructured":"Pittman, P.R. (2017, August 25). Safety and Immunogenicity of Live-Attenuated MP-12 Rift Valley Fever Vaccine (ZH548, MP12, TSI-GSD-223 Lot 7-2-88) in Humans, and Genetic Characterization of Virus Isolates Recovered from Blood of Vaccinated Volunteers: A Phase II Study, Available online: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00415051."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: A 12-year experience","volume":"18","author":"Pittman","year":"2000","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.virusres.2011.10.023","article-title":"Animal models of Rift Valley fever virus infection","volume":"163","author":"Ross","year":"2012","journal-title":"Virus Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virol.2015.12.003","article-title":"Development of a sheep challenge model for Rift Valley fever","volume":"489","author":"Faburay","year":"2016","journal-title":"Virology"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wilson, W.C., Davis, A.S., Gaudreault, N.N., Faburay, B., Trujillo, J.D., Shivanna, V., Sunwoo, S.Y., Balogh, A., Endalew, A., and Ma, W. (2016). Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus. Viruses, 8.","DOI":"10.3390\/v8050145"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.vaccine.2014.02.066","article-title":"Development of a Rift Valley fever virus viremia challenge model in sheep and goats","volume":"32","author":"Weingartl","year":"2014","journal-title":"Vaccine"},{"key":"ref_73","first-page":"45","article-title":"An inactivated Rift Valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J. S. Afr. Vet. Assoc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0065-3519(99)80043-3","article-title":"Vaccination of wildlife against rabies: Successful use of a vectored vaccine obtained by recombinant technology","volume":"41","author":"Mackowiak","year":"1999","journal-title":"Adv. Vet. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.89.5.660","article-title":"The development of a formalin-killed Rift Valley fever virus vaccine for use in man","volume":"89","author":"Randall","year":"1962","journal-title":"J. Immunol."},{"key":"ref_76","first-page":"124","article-title":"Rift Valley fever vaccine for humans","volume":"3","author":"Eddy","year":"1981","journal-title":"Contr. Epidem. Biostatist."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2460\/ajvr.1980.41.10.1559","article-title":"Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep","volume":"41","author":"Harrington","year":"1980","journal-title":"Am. J. Vet. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jir354","article-title":"Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine","volume":"204","author":"Morrill","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"Engelbrecht","year":"2011","journal-title":"Vaccine"},{"key":"ref_83","first-page":"295","article-title":"Evaluation of the safety and efficacy of a live attenuated thermostable Rift Valley fever vaccine in sheep, goats and cattle","volume":"6","author":"Daouam","year":"2015","journal-title":"J. Vaccines Vaccin."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Daouam, S., Ghzal, F., Naouli, Y., Tadlaoui, K.O., Ennaji, M.M., Oura, C., and El Harrak, M. (2016). Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels. BMC Vet. Res., 12.","DOI":"10.1186\/s12917-016-0775-8"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1016\/j.vaccine.2014.07.037","article-title":"Comparative efficacy of two next-generation Rift Valley fever vaccines","volume":"32","author":"Kortekaas","year":"2014","journal-title":"Vaccine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2013.08.003","article-title":"Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1128\/JVI.00961-14","article-title":"Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging","volume":"88","author":"Oreshkova","year":"2014","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.vaccine.2015.01.077","article-title":"Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination","volume":"33","author":"Kant","year":"2015","journal-title":"Vaccine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-5-82","article-title":"Rift Valley fever virus structural proteins: Expression, characterization and assembly of recombinant proteins","volume":"5","author":"Liu","year":"2008","journal-title":"Virol. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1128\/CVI.00220-10","article-title":"Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine","volume":"17","author":"Soi","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1073\/pnas.1112149108","article-title":"Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice","volume":"108","author":"Papin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.vaccine.2010.01.001","article-title":"Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2014.05.020","article-title":"Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs","volume":"108","author":"Busquets","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12985-017-0811-8","article-title":"An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep","volume":"14","author":"Said","year":"2017","journal-title":"Virol. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against Rift Valley Fever Virus. Studies on the Immunogenicity of Lyophilized Formalin-Inactivated Vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0264-410X(85)90061-1","article-title":"Rift Valley fever virus vaccine trial: Study of neutralizing antibody response in humans","volume":"3","author":"Niklasson","year":"1985","journal-title":"Vaccine"},{"key":"ref_98","unstructured":"World Health Organization (WHO) (1983). The use of veterinary vaccines for prevention and control of Rift Valley fever: Memorandum from WHO\/FAO meeting. Bull. World Health Organ., 61, 261\u2013268."},{"key":"ref_99","first-page":"107","article-title":"Rift Valley fever; isolation of the virus from wild mosquitoes","volume":"29","author":"Smithburn","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0034-5288(18)34599-5","article-title":"The immunity induced in cattle and sheep by inoculation of neurotropic or pantropic Rift Valley fever viruses","volume":"8","author":"Coackley","year":"1967","journal-title":"Res. Vet. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/195583a0","article-title":"Neutralizing antibody response of sheep to pantropic and neutrotropic rift valley fever virus","volume":"195","author":"Capstick","year":"1962","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1128\/JVI.73.10.8196-8200.1999","article-title":"Genetic reassortment of Rift Valley fever virus in nature","volume":"73","author":"Sall","year":"1999","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S0074-02761998000500009","article-title":"Molecular epidemiology and emergence of Rift Valley fever","volume":"93","author":"Sall","year":"1998","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of Rift Valley fever virus","volume":"95","author":"Ikegami","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1099\/0022-1317-71-10-2307","article-title":"Generation and transmission of Rift Valley fever viral reassortants by the mosquito Culex pipiens","volume":"71 Pt 10","author":"Turell","year":"1990","journal-title":"J. Gen. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir249","article-title":"Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus","volume":"204","author":"Morrill","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_107","unstructured":"Saluzzo, J.F., and Dodet, B. (1997). Emergence of Rift Valley fever. Factors in the Emergence of Arbovirus Diseases, Elsevier."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0034-5288(92)90029-2","article-title":"Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine","volume":"52","author":"Baskerville","year":"1992","journal-title":"Res. Vet. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am. J. Vet. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4269\/ajtmh.1986.35.660","article-title":"Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus","volume":"35","author":"Moussa","year":"1986","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2460\/ajvr.1991.52.01.50","article-title":"Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever","volume":"52","author":"Hubbard","year":"1991","journal-title":"Am. J. Vet. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am. J. Vet. Res."},{"key":"ref_114","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3389\/fmicb.2016.01889","article-title":"Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells","volume":"7","author":"Faburay","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1099\/0022-1317-34-3-557","article-title":"Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells","volume":"34","author":"Swanepoel","year":"1977","journal-title":"J. Gen. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1128\/JVI.73.6.5018-5025.1999","article-title":"The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein","volume":"73","author":"Yadani","year":"1999","journal-title":"J. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JVI.01165-09","article-title":"Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects","volume":"84","author":"Mansuroglu","year":"2010","journal-title":"J. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Xu, W., Watts, D.M., Costanzo, M.C., Tang, X., Venegas, L.A., Jiao, F., Sette, A., Sidney, J., Sewell, A.K., and Wooldridge, L. (2013). The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059210"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Van Vuren, P.J., Tiemessen, C.T., and Paweska, J.T. (2011). Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025027"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2011.08.025","article-title":"Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins","volume":"420","author":"Gavrilov","year":"2011","journal-title":"Virology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vbz.2012.1285","article-title":"Rift Valley fever virus structural and nonstructural proteins: Recombinant protein expression and immunoreactivity against antisera from sheep","volume":"13","author":"Faburay","year":"2013","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-\/-) mice induced by different DNA vaccination regimens","volume":"28","author":"Lorenzo","year":"2010","journal-title":"Vaccine"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1016\/j.vaccine.2011.04.043","article-title":"A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(\u2212\/\u2212) mice upon lethal virus challenge","volume":"29","author":"Boshra","year":"2011","journal-title":"Vaccine"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1863-2378.2012.01478.x","article-title":"Virus-like particle-based countermeasures against Rift Valley fever virus","volume":"59","author":"Koukuntla","year":"2012","journal-title":"Zoonoses Public Health"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2009.0248","article-title":"Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus","volume":"10","author":"Pichlmair","year":"2010","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1568005014605973","article-title":"Bacterial carriers and virus-like-particles as antigen delivery devices: Role of dendritic cells in antigen presentation","volume":"1","author":"Beyer","year":"2001","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"ref_128","first-page":"3478","article-title":"Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells","volume":"63","author":"Fausch","year":"2003","journal-title":"Cancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.vaccine.2004.09.035","article-title":"Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells","volume":"23","author":"Fausch","year":"2005","journal-title":"Vaccine"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000150482","article-title":"Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen","volume":"39","author":"Schirmbeck","year":"1996","journal-title":"Intervirology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1073\/pnas.94.14.7503","article-title":"Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells","volume":"94","author":"Sedlik","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Njenga, M.K., Njagi, L., Thumbi, S.M., Kahariri, S., Githinji, J., Omondi, E., Baden, A., Murithi, M., Paweska, J., and Ithondeka, P.M. (2015). Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003550"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4102\/ojvr.v82i1.857","article-title":"Safety and immunogenicity of Onderstepoort Biological Products\u2019 Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal","volume":"82","author":"Lo","year":"2015","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Makoschey, B., van Kilsdonk, E., Hubers, W.R., Vrijenhoek, M.P., Smit, M., Wichgers Schreur, P.J., Kortekaas, J., and Moulin, V. (2016). Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004550"},{"key":"ref_135","unstructured":"Food and Agriculture Organization of the United Nations (FAO) (2014, January 5\u20137). The Last Hurdles towards Rift Valley Fever Control. Proceedings of the Ad Hoc Workshop on the Current State of Rift Valley Vaccine and Diagnostics Development, Rome, Italy."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.vaccine.2013.12.064","article-title":"Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep","volume":"32","author":"Weingartl","year":"2014","journal-title":"Vaccine"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.vaccine.2017.04.024","article-title":"Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy","volume":"35","author":"Kant","year":"2017","journal-title":"Vaccine"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1217134","article-title":"Attenuated vaccines can recombine to form virulent field viruses","volume":"337","author":"Lee","year":"2012","journal-title":"Science"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4269\/ajtmh.2010.09-0291","article-title":"An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya","volume":"83","author":"Rich","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","article-title":"Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007","volume":"83","author":"Mohamed","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.2010.09-0289","article-title":"Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006\u20132008 and possible vector control strategies","volume":"83","author":"Anyamba","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Metras, R., Porphyre, T., Pfeiffer, D.U., Kemp, A., Thompson, P.N., Collins, L.M., and White, R.G. (2012). Exploratory space-time analyses of Rift Valley Fever in South Africa in 2008\u20132011. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001808"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3201\/eid1912.130593","article-title":"Rift Valley fever in Namibia, 2010","volume":"19","author":"Monaco","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e864","DOI":"10.1016\/S2214-109X(16)30176-0","article-title":"Association of Rift Valley fever virus infection with miscarriage in Sudanese women: A cross-sectional study","volume":"4","author":"Baudin","year":"2016","journal-title":"Lancet Glob. Health"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"ofw149","DOI":"10.1093\/ofid\/ofw149","article-title":"Widespread Rift Valley Fever Emergence in Senegal in 2013\u20132014","volume":"3","author":"Sow","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"ofw200","DOI":"10.1093\/ofid\/ofw200","article-title":"Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015","volume":"3","author":"Boushab","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.15585\/mmwr.mm6543a5","article-title":"Notes from the Field: Rift Valley Fever Response\u2014Kabale District, Uganda, March 2016","volume":"65","author":"Maurice","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_148","unstructured":"World Health Organization (WHO) (2017, August 25). Disease Outbreak News, Rift Valley Fever in Niger. Available online: http:\/\/www.who.int\/csr\/don\/29-september-2016-rift-valley-fever-niger\/en\/."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","article-title":"Breaking the chain: Rift Valley fever virus control via livestock vaccination","volume":"2","author":"Bird","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.285.5426.397","article-title":"Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya","volume":"285","author":"Linthicum","year":"1999","journal-title":"Science"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.3823909","article-title":"Detection of Rift Valley fever viral activity in Kenya by satellite remote sensing imagery","volume":"235","author":"Linthicum","year":"1987","journal-title":"Science"},{"key":"ref_152","first-page":"28132","article-title":"The case for a \u2018one health\u2019 approach to combating vector-borne diseases","volume":"5","author":"Faburay","year":"2015","journal-title":"Infect. Ecol. Epidemiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"F64","DOI":"10.1016\/j.vaccine.2010.03.055","article-title":"Vaccination strategies for managing brucellosis in Yellowstone bison","volume":"28","author":"Treanor","year":"2010","journal-title":"Vaccine"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vetimm.2013.09.001","article-title":"Eradication of bluetongue disease in Germany by vaccination","volume":"158","author":"Baetza","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"20120139","DOI":"10.1098\/rstb.2012.0139","article-title":"Rinderpest: The veterinary perspective on eradication","volume":"368","author":"Roeder","year":"2013","journal-title":"Phil. Trans. R. Soc. B"},{"key":"ref_156","unstructured":"African Union (AU) (2010, January 13\u201314). History of rinderpest eradication from Africa: Impact, lessons learnt and way forward. Proceedings of the Agriculture Ministers\u2019 Conference, Entebbe, Uganda. Inter-African Bureau of Animal Resources (IBAR) Position Paper."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/5\/3\/29\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:45:20Z","timestamp":1760208320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/5\/3\/29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":156,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["vaccines5030029"],"URL":"https:\/\/doi.org\/10.3390\/vaccines5030029","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]}}}